Indian J Palliat Care Home 
 

ORIGINAL ARTICLE
Year : 2021  |  Volume : 27  |  Issue : 1  |  Page : 104--108

The burden of cancer-related neuropathic pain: A multi-centric cross-sectional observational study from North India

Aanchal Satija1, Anjum Khan Joad2, Shiv Pratap Singh Rana3, Sushma Bhatnagar1 
1 Department of Onco-Anesthesia and Palliative Medicine, Dr B.R. Ambedkar, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
2 Department of Anesthesia and Palliative Care, Bhagwan Mahaveer Cancer Hospital and Research Centre, Jawahar Lal Nehru Marg, Jaipur, Rajasthan, India
3 Department of Pain and Palliative Medicine, Fortis Hospital, Noida, Uttar Pradesh, India

Correspondence Address:
Anjum Khan Joad
Department of Anesthesia and Palliative Care, Bhagwan Mahaveer Cancer Hospital and Research Centre, Jawahar Lal Nehru Marg, Jaipur - 302 017, Rajasthan
India

Introduction: Neuropathic cancer pain is a common consequence of cancer itself and anti-cancer treatments. It is a complex phenomenon, often underdiagnosed by physicians or underreported by patients. Its diagnosis and management are usually more challenging than nociceptive pain. There is a dearth of epidemiological evidence for neuropathic pain in cancer patients in India. Screening questionnaires serve as a quick guide to identify potential cases of neuropathic pain. The aim of the present study was to identify the burden of cancer-related neuropathic pain using the Self-reported version of the Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale. Methodology: This was a cross-sectional, observational, multi-centric study conducted at three hospitals in North India. From January 2017 to October 2017, patients attending pain clinic were screened for participation in the study. Adults aged ≥18 years and experiencing the pain of oncologic origin were eligible to participate in the study if they provided informed consent. S-LANSS questionnaire was used to screen patients with neuropathic pain. Results: From a total of 261 patients, who were enrolled in the study, 56.7% were male and their mean age was 50.87 (18–80) years. Fifty-four percent patients had pain with predominantly neuropathic component (S-LANSS score ≥10). Conclusion: High burden of neuropathic cancer pain has been observed in outpatient palliative care settings. Early diagnosis of neuropathic pain through screening questionnaires can serve as a quick guide for physicians in resource-constrained settings. This will allow identification of the neuropathic component of pain in patients suffering with mixed pain.


How to cite this article:
Satija A, Joad AK, Rana SP, Bhatnagar S. The burden of cancer-related neuropathic pain: A multi-centric cross-sectional observational study from North India.Indian J Palliat Care 2021;27:104-108


How to cite this URL:
Satija A, Joad AK, Rana SP, Bhatnagar S. The burden of cancer-related neuropathic pain: A multi-centric cross-sectional observational study from North India. Indian J Palliat Care [serial online] 2021 [cited 2021 May 14 ];27:104-108
Available from: https://www.jpalliativecare.com/article.asp?issn=0973-1075;year=2021;volume=27;issue=1;spage=104;epage=108;aulast=Satija;type=0